ArticleBlood advances2024

Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status.

Alexandra Dolnikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.